Click for best price
Ulcerative Colitis Immunology Drugs Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Ulcerative Colitis Immunology Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ulcerative Colitis Immunology Drugs. This report contains market size and forecasts of Ulcerative Colitis Immunology Drugs in global, including the following market information:
Global Ulcerative Colitis Immunology Drugs Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Ulcerative Colitis Immunology Drugs Market Sales, 2018-2023, 2024-2032, (K Pcs)
Global top five Ulcerative Colitis Immunology Drugs companies in 2022 (%)
The global Ulcerative Colitis Immunology Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Adalimumab Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Ulcerative Colitis Immunology Drugs include Janssen Biotech, Inc., Bristol-Myers Squibb Company, AbbVie Inc., UCBCares, AMGEN, Celltrion Healthcare, Biogen, Genentech USA, Inc. and ROCHE, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Ulcerative Colitis Immunology Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ulcerative Colitis Immunology Drugs Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global Ulcerative Colitis Immunology Drugs Market Segment Percentages, by Type, 2022 (%)
Adalimumab
Certolizumab Pegol
Tofacitinib
Etanercept
Golimumab
Abatacept
Infliximab
Others
Global Ulcerative Colitis Immunology Drugs Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global Ulcerative Colitis Immunology Drugs Market Segment Percentages, by Application, 2022 (%)
Rheumatoid Arthritis
Crohn's Disease(CD)
Ankylosing Spondylitis(AS)
Psoriasis(Ps)
Ulcerative Colitis(UC)
Global Ulcerative Colitis Immunology Drugs Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global Ulcerative Colitis Immunology Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ulcerative Colitis Immunology Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Ulcerative Colitis Immunology Drugs revenues share in global market, 2022 (%)
Key companies Ulcerative Colitis Immunology Drugs sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Ulcerative Colitis Immunology Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Janssen Biotech, Inc.
Bristol-Myers Squibb Company
AbbVie Inc.
UCBCares
AMGEN
Celltrion Healthcare
Biogen
Genentech USA, Inc.
ROCHE
Pfizer Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ulcerative Colitis Immunology Drugs, market overview.
Chapter 2: Global Ulcerative Colitis Immunology Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Ulcerative Colitis Immunology Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ulcerative Colitis Immunology Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Ulcerative Colitis Immunology Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Ulcerative Colitis Immunology Drugs Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
78 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Ulcerative Colitis Immunology Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ulcerative Colitis Immunology Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ulcerative Colitis Immunology Drugs Overall Market Size
2.1 Global Ulcerative Colitis Immunology Drugs Market Size: 2022 VS 2030
2.2 Global Ulcerative Colitis Immunology Drugs Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Ulcerative Colitis Immunology Drugs Sales: 2018-2030
3 Company Landscape
3.1 Top Ulcerative Colitis Immunology Drugs Players in Global Market
3.2 Top Global Ulcerative Colitis Immunology Drugs Companies Ranked by Revenue
3.3 Global Ulcerative Colitis Immunology Drugs Revenue by Companies
3.4 Global Ulcerative Colitis Immunology Drugs Sales by Companies
3.5 Global Ulcerative Colitis Immunology Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Ulcerative Colitis Immunology Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Ulcerative Colitis Immunology Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Ulcerative Colitis Immunology Drugs Players in Global Market
3.8.1 List of Global Tier 1 Ulcerative Colitis Immunology Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Ulcerative Colitis Immunology Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Ulcerative Colitis Immunology Drugs Market Size Markets, 2022 & 2030
4.1.2 Adalimumab
4.1.3 Certolizumab Pegol
4.1.4 Tofacitinib
4.1.5 Etanercept
4.1.6 Golimumab
4.1.7 Abatacept
4.1.8 Infliximab
4.1.9 Others
4.2 By Type - Global Ulcerative Colitis Immunology Drugs Revenue & Forecasts
4.2.1 By Type - Global Ulcerative Colitis Immunology Drugs Revenue, 2018-2023
4.2.2 By Type - Global Ulcerative Colitis Immunology Drugs Revenue, 2024-2030
4.2.3 By Type - Global Ulcerative Colitis Immunology Drugs Revenue Market Share, 2018-2030
4.3 By Type - Global Ulcerative Colitis Immunology Drugs Sales & Forecasts
4.3.1 By Type - Global Ulcerative Colitis Immunology Drugs Sales, 2018-2023
4.3.2 By Type - Global Ulcerative Colitis Immunology Drugs Sales, 2024-2030
4.3.3 By Type - Global Ulcerative Colitis Immunology Drugs Sales Market Share, 2018-2030
4.4 By Type - Global Ulcerative Colitis Immunology Drugs Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ulcerative Colitis Immunology Drugs Market Size, 2022 & 2030
5.1.2 Rheumatoid Arthritis
5.1.3 Crohn's Disease(CD)
5.1.4 Ankylosing Spondylitis(AS)
5.1.5 Psoriasis(Ps)
5.1.6 Ulcerative Colitis(UC)
5.2 By Application - Global Ulcerative Colitis Immunology Drugs Revenue & Forecasts
5.2.1 By Application - Global Ulcerative Colitis Immunology Drugs Revenue, 2018-2023
5.2.2 By Application - Global Ulcerative Colitis Immunology Drugs Revenue, 2024-2030
5.2.3 By Application - Global Ulcerative Colitis Immunology Drugs Revenue Market Share, 2018-2030
5.3 By Application - Global Ulcerative Colitis Immunology Drugs Sales & Forecasts
5.3.1 By Application - Global Ulcerative Colitis Immunology Drugs Sales, 2018-2023
5.3.2 By Application - Global Ulcerative Colitis Immunology Drugs Sales, 2024-2030
5.3.3 By Application - Global Ulcerative Colitis Immunology Drugs Sales Market Share, 2018-2030
5.4 By Application - Global Ulcerative Colitis Immunology Drugs Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Ulcerative Colitis Immunology Drugs Market Size, 2022 & 2030
6.2 By Region - Global Ulcerative Colitis Immunology Drugs Revenue & Forecasts
6.2.1 By Region - Global Ulcerative Colitis Immunology Drugs Revenue, 2018-2023
6.2.2 By Region - Global Ulcerative Colitis Immunology Drugs Revenue, 2024-2030
6.2.3 By Region - Global Ulcerative Colitis Immunology Drugs Revenue Market Share, 2018-2030
6.3 By Region - Global Ulcerative Colitis Immunology Drugs Sales & Forecasts
6.3.1 By Region - Global Ulcerative Colitis Immunology Drugs Sales, 2018-2023
6.3.2 By Region - Global Ulcerative Colitis Immunology Drugs Sales, 2024-2030
6.3.3 By Region - Global Ulcerative Colitis Immunology Drugs Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Ulcerative Colitis Immunology Drugs Revenue, 2018-2030
6.4.2 By Country - North America Ulcerative Colitis Immunology Drugs Sales, 2018-2030
6.4.3 US Ulcerative Colitis Immunology Drugs Market Size, 2018-2030
6.4.4 Canada Ulcerative Colitis Immunology Drugs Market Size, 2018-2030
6.4.5 Mexico Ulcerative Colitis Immunology Drugs Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Ulcerative Colitis Immunology Drugs Revenue, 2018-2030
6.5.2 By Country - Europe Ulcerative Colitis Immunology Drugs Sales, 2018-2030
6.5.3 Germany Ulcerative Colitis Immunology Drugs Market Size, 2018-2030
6.5.4 France Ulcerative Colitis Immunology Drugs Market Size, 2018-2030
6.5.5 U.K. Ulcerative Colitis Immunology Drugs Market Size, 2018-2030
6.5.6 Italy Ulcerative Colitis Immunology Drugs Market Size, 2018-2030
6.5.7 Russia Ulcerative Colitis Immunology Drugs Market Size, 2018-2030
6.5.8 Nordic Countries Ulcerative Colitis Immunology Drugs Market Size, 2018-2030
6.5.9 Benelux Ulcerative Colitis Immunology Drugs Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Ulcerative Colitis Immunology Drugs Revenue, 2018-2030
6.6.2 By Region - Asia Ulcerative Colitis Immunology Drugs Sales, 2018-2030
6.6.3 China Ulcerative Colitis Immunology Drugs Market Size, 2018-2030
6.6.4 Japan Ulcerative Colitis Immunology Drugs Market Size, 2018-2030
6.6.5 South Korea Ulcerative Colitis Immunology Drugs Market Size, 2018-2030
6.6.6 Southeast Asia Ulcerative Colitis Immunology Drugs Market Size, 2018-2030
6.6.7 India Ulcerative Colitis Immunology Drugs Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Ulcerative Colitis Immunology Drugs Revenue, 2018-2030
6.7.2 By Country - South America Ulcerative Colitis Immunology Drugs Sales, 2018-2030
6.7.3 Brazil Ulcerative Colitis Immunology Drugs Market Size, 2018-2030
6.7.4 Argentina Ulcerative Colitis Immunology Drugs Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Ulcerative Colitis Immunology Drugs Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Ulcerative Colitis Immunology Drugs Sales, 2018-2030
6.8.3 Turkey Ulcerative Colitis Immunology Drugs Market Size, 2018-2030
6.8.4 Israel Ulcerative Colitis Immunology Drugs Market Size, 2018-2030
6.8.5 Saudi Arabia Ulcerative Colitis Immunology Drugs Market Size, 2018-2030
6.8.6 UAE Ulcerative Colitis Immunology Drugs Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Janssen Biotech, Inc.
7.1.1 Janssen Biotech, Inc. Company Summary
7.1.2 Janssen Biotech, Inc. Business Overview
7.1.3 Janssen Biotech, Inc. Ulcerative Colitis Immunology Drugs Major Product Offerings
7.1.4 Janssen Biotech, Inc. Ulcerative Colitis Immunology Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Janssen Biotech, Inc. Key News & Latest Developments
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Company Summary
7.2.2 Bristol-Myers Squibb Company Business Overview
7.2.3 Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Major Product Offerings
7.2.4 Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.3 AbbVie Inc.
7.3.1 AbbVie Inc. Company Summary
7.3.2 AbbVie Inc. Business Overview
7.3.3 AbbVie Inc. Ulcerative Colitis Immunology Drugs Major Product Offerings
7.3.4 AbbVie Inc. Ulcerative Colitis Immunology Drugs Sales and Revenue in Global (2018-2023)
7.3.5 AbbVie Inc. Key News & Latest Developments
7.4 UCBCares
7.4.1 UCBCares Company Summary
7.4.2 UCBCares Business Overview
7.4.3 UCBCares Ulcerative Colitis Immunology Drugs Major Product Offerings
7.4.4 UCBCares Ulcerative Colitis Immunology Drugs Sales and Revenue in Global (2018-2023)
7.4.5 UCBCares Key News & Latest Developments
7.5 AMGEN
7.5.1 AMGEN Company Summary
7.5.2 AMGEN Business Overview
7.5.3 AMGEN Ulcerative Colitis Immunology Drugs Major Product Offerings
7.5.4 AMGEN Ulcerative Colitis Immunology Drugs Sales and Revenue in Global (2018-2023)
7.5.5 AMGEN Key News & Latest Developments
7.6 Celltrion Healthcare
7.6.1 Celltrion Healthcare Company Summary
7.6.2 Celltrion Healthcare Business Overview
7.6.3 Celltrion Healthcare Ulcerative Colitis Immunology Drugs Major Product Offerings
7.6.4 Celltrion Healthcare Ulcerative Colitis Immunology Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Celltrion Healthcare Key News & Latest Developments
7.7 Biogen
7.7.1 Biogen Company Summary
7.7.2 Biogen Business Overview
7.7.3 Biogen Ulcerative Colitis Immunology Drugs Major Product Offerings
7.7.4 Biogen Ulcerative Colitis Immunology Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Biogen Key News & Latest Developments
7.8 Genentech USA, Inc.
7.8.1 Genentech USA, Inc. Company Summary
7.8.2 Genentech USA, Inc. Business Overview
7.8.3 Genentech USA, Inc. Ulcerative Colitis Immunology Drugs Major Product Offerings
7.8.4 Genentech USA, Inc. Ulcerative Colitis Immunology Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Genentech USA, Inc. Key News & Latest Developments
7.9 ROCHE
7.9.1 ROCHE Company Summary
7.9.2 ROCHE Business Overview
7.9.3 ROCHE Ulcerative Colitis Immunology Drugs Major Product Offerings
7.9.4 ROCHE Ulcerative Colitis Immunology Drugs Sales and Revenue in Global (2018-2023)
7.9.5 ROCHE Key News & Latest Developments
7.10 Pfizer Inc.
7.10.1 Pfizer Inc. Company Summary
7.10.2 Pfizer Inc. Business Overview
7.10.3 Pfizer Inc. Ulcerative Colitis Immunology Drugs Major Product Offerings
7.10.4 Pfizer Inc. Ulcerative Colitis Immunology Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Pfizer Inc. Key News & Latest Developments
8 Global Ulcerative Colitis Immunology Drugs Production Capacity, Analysis
8.1 Global Ulcerative Colitis Immunology Drugs Production Capacity, 2018-2030
8.2 Ulcerative Colitis Immunology Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Ulcerative Colitis Immunology Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Ulcerative Colitis Immunology Drugs Supply Chain Analysis
10.1 Ulcerative Colitis Immunology Drugs Industry Value Chain
10.2 Ulcerative Colitis Immunology Drugs Upstream Market
10.3 Ulcerative Colitis Immunology Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Ulcerative Colitis Immunology Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Ulcerative Colitis Immunology Drugs in Global Market
Table 2. Top Ulcerative Colitis Immunology Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Ulcerative Colitis Immunology Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Ulcerative Colitis Immunology Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Ulcerative Colitis Immunology Drugs Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Ulcerative Colitis Immunology Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Ulcerative Colitis Immunology Drugs Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Ulcerative Colitis Immunology Drugs Product Type
Table 9. List of Global Tier 1 Ulcerative Colitis Immunology Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ulcerative Colitis Immunology Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Ulcerative Colitis Immunology Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Ulcerative Colitis Immunology Drugs Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Ulcerative Colitis Immunology Drugs Sales (K Pcs), 2018-2023
Table 15. By Type - Global Ulcerative Colitis Immunology Drugs Sales (K Pcs), 2024-2030
Table 16. By Application ? Global Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Ulcerative Colitis Immunology Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Ulcerative Colitis Immunology Drugs Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Ulcerative Colitis Immunology Drugs Sales (K Pcs), 2018-2023
Table 20. By Application - Global Ulcerative Colitis Immunology Drugs Sales (K Pcs), 2024-2030
Table 21. By Region ? Global Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Ulcerative Colitis Immunology Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Ulcerative Colitis Immunology Drugs Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Ulcerative Colitis Immunology Drugs Sales (K Pcs), 2018-2023
Table 25. By Region - Global Ulcerative Colitis Immunology Drugs Sales (K Pcs), 2024-2030
Table 26. By Country - North America Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Ulcerative Colitis Immunology Drugs Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Ulcerative Colitis Immunology Drugs Sales, (K Pcs), 2024-2030
Table 30. By Country - Europe Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Ulcerative Colitis Immunology Drugs Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Ulcerative Colitis Immunology Drugs Sales, (K Pcs), 2024-2030
Table 34. By Region - Asia Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Ulcerative Colitis Immunology Drugs Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Ulcerative Colitis Immunology Drugs Sales, (K Pcs), 2024-2030
Table 38. By Country - South America Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Ulcerative Colitis Immunology Drugs Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Ulcerative Colitis Immunology Drugs Sales, (K Pcs), 2024-2030
Table 42. By Country - Middle East & Africa Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Ulcerative Colitis Immunology Drugs Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Ulcerative Colitis Immunology Drugs Sales, (K Pcs), 2024-2030
Table 46. Janssen Biotech, Inc. Company Summary
Table 47. Janssen Biotech, Inc. Ulcerative Colitis Immunology Drugs Product Offerings
Table 48. Janssen Biotech, Inc. Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Janssen Biotech, Inc. Key News & Latest Developments
Table 50. Bristol-Myers Squibb Company Company Summary
Table 51. Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Product Offerings
Table 52. Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Bristol-Myers Squibb Company Key News & Latest Developments
Table 54. AbbVie Inc. Company Summary
Table 55. AbbVie Inc. Ulcerative Colitis Immunology Drugs Product Offerings
Table 56. AbbVie Inc. Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. AbbVie Inc. Key News & Latest Developments
Table 58. UCBCares Company Summary
Table 59. UCBCares Ulcerative Colitis Immunology Drugs Product Offerings
Table 60. UCBCares Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. UCBCares Key News & Latest Developments
Table 62. AMGEN Company Summary
Table 63. AMGEN Ulcerative Colitis Immunology Drugs Product Offerings
Table 64. AMGEN Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. AMGEN Key News & Latest Developments
Table 66. Celltrion Healthcare Company Summary
Table 67. Celltrion Healthcare Ulcerative Colitis Immunology Drugs Product Offerings
Table 68. Celltrion Healthcare Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. Celltrion Healthcare Key News & Latest Developments
Table 70. Biogen Company Summary
Table 71. Biogen Ulcerative Colitis Immunology Drugs Product Offerings
Table 72. Biogen Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Biogen Key News & Latest Developments
Table 74. Genentech USA, Inc. Company Summary
Table 75. Genentech USA, Inc. Ulcerative Colitis Immunology Drugs Product Offerings
Table 76. Genentech USA, Inc. Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Genentech USA, Inc. Key News & Latest Developments
Table 78. ROCHE Company Summary
Table 79. ROCHE Ulcerative Colitis Immunology Drugs Product Offerings
Table 80. ROCHE Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. ROCHE Key News & Latest Developments
Table 82. Pfizer Inc. Company Summary
Table 83. Pfizer Inc. Ulcerative Colitis Immunology Drugs Product Offerings
Table 84. Pfizer Inc. Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. Pfizer Inc. Key News & Latest Developments
Table 86. Ulcerative Colitis Immunology Drugs Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 87. Global Ulcerative Colitis Immunology Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Ulcerative Colitis Immunology Drugs Production by Region, 2018-2023 (K Pcs)
Table 89. Global Ulcerative Colitis Immunology Drugs Production by Region, 2024-2030 (K Pcs)
Table 90. Ulcerative Colitis Immunology Drugs Market Opportunities & Trends in Global Market
Table 91. Ulcerative Colitis Immunology Drugs Market Drivers in Global Market
Table 92. Ulcerative Colitis Immunology Drugs Market Restraints in Global Market
Table 93. Ulcerative Colitis Immunology Drugs Raw Materials
Table 94. Ulcerative Colitis Immunology Drugs Raw Materials Suppliers in Global Market
Table 95. Typical Ulcerative Colitis Immunology Drugs Downstream
Table 96. Ulcerative Colitis Immunology Drugs Downstream Clients in Global Market
Table 97. Ulcerative Colitis Immunology Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Ulcerative Colitis Immunology Drugs Segment by Type in 2022
Figure 2. Ulcerative Colitis Immunology Drugs Segment by Application in 2022
Figure 3. Global Ulcerative Colitis Immunology Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Ulcerative Colitis Immunology Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Ulcerative Colitis Immunology Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. Ulcerative Colitis Immunology Drugs Sales in Global Market: 2018-2030 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Ulcerative Colitis Immunology Drugs Revenue in 2022
Figure 9. By Type - Global Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Ulcerative Colitis Immunology Drugs Revenue Market Share, 2018-2030
Figure 11. By Type - Global Ulcerative Colitis Immunology Drugs Sales Market Share, 2018-2030
Figure 12. By Type - Global Ulcerative Colitis Immunology Drugs Price (USD/Pcs), 2018-2030
Figure 13. By Application - Global Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Ulcerative Colitis Immunology Drugs Revenue Market Share, 2018-2030
Figure 15. By Application - Global Ulcerative Colitis Immunology Drugs Sales Market Share, 2018-2030
Figure 16. By Application - Global Ulcerative Colitis Immunology Drugs Price (USD/Pcs), 2018-2030
Figure 17. By Region - Global Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Ulcerative Colitis Immunology Drugs Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Ulcerative Colitis Immunology Drugs Revenue Market Share, 2018-2030
Figure 20. By Region - Global Ulcerative Colitis Immunology Drugs Sales Market Share, 2018-2030
Figure 21. By Country - North America Ulcerative Colitis Immunology Drugs Revenue Market Share, 2018-2030
Figure 22. By Country - North America Ulcerative Colitis Immunology Drugs Sales Market Share, 2018-2030
Figure 23. US Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Ulcerative Colitis Immunology Drugs Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Ulcerative Colitis Immunology Drugs Sales Market Share, 2018-2030
Figure 28. Germany Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. France Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Ulcerative Colitis Immunology Drugs Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Ulcerative Colitis Immunology Drugs Sales Market Share, 2018-2030
Figure 37. China Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. India Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Ulcerative Colitis Immunology Drugs Revenue Market Share, 2018-2030
Figure 43. By Country - South America Ulcerative Colitis Immunology Drugs Sales Market Share, 2018-2030
Figure 44. Brazil Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Ulcerative Colitis Immunology Drugs Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Ulcerative Colitis Immunology Drugs Sales Market Share, 2018-2030
Figure 48. Turkey Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2018-2030
Figure 52. Global Ulcerative Colitis Immunology Drugs Production Capacity (K Pcs), 2018-2030
Figure 53. The Percentage of Production Ulcerative Colitis Immunology Drugs by Region, 2022 VS 2030
Figure 54. Ulcerative Colitis Immunology Drugs Industry Value Chain
Figure 55. Marketing Channels
